Phase Ia clinical evaluation of the safety and immunogenicity of the Plasmodium falciparum blood-stage antigen AMA1 in ChAd63 and MVA vaccine vectors. [electronic resource]
Producer: 20120629Description: e31208 p. digitalISSN:- 1932-6203
- Adenoviruses, Simian -- genetics
- Adolescent
- Adult
- Animals
- Antibodies, Neutralizing -- immunology
- Antibodies, Protozoan -- immunology
- Antigens, Protozoan -- immunology
- Enzyme-Linked Immunospot Assay
- Female
- Genetic Vectors -- genetics
- Humans
- Immunization
- Interferon-gamma -- immunology
- Life Cycle Stages
- Malaria Vaccines -- adverse effects
- Malaria, Falciparum -- immunology
- Male
- Middle Aged
- Plasmodium falciparum -- growth & development
- T-Lymphocytes -- immunology
- Vaccinia virus -- genetics
- Young Adult
No physical items for this record
Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.